Defective Immune Response to SARS-CoV-2 Immunization in Down Syndrome Correlates With Increased Susceptibility to Severe Illness With Infection

Affiliations

Editorial

T Prescott Atkinson. J Infect Dis. 2022.

. 2022 Sep 13;226(5):755-756.

doi: 10.1093/infdis/jiac237.

¹ Division of Pediatric Allergy and Immunology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

No abstract available

Comment on

Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome.
Streng BMM, Bont M, Delemarre EM, Binnendijk RS, Smit G, den Hartog G, Coppus AMW, de Vries E, Weijerman ME, Lamberts R, de Graaf G, van der Klis FR, Vidarsson G, Rave N, Bont LJ, Wildenbeest JG. Streng BMM, et al. J Infect Dis. 2022 Sep 4;226(4):673-677. doi: 10.1093/infdis/jiac235. J Infect Dis. 2022. PMID: 35748853 Free PMC article.
Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.
Ku JH, Levin MJ, Luo Y, Florea A, Lin IC, Tian Y, Tseng HF. Ku JH, et al. J Infect Dis. 2022 Sep 13;226(5):757-765. doi: 10.1093/infdis/jiac236. J Infect Dis. 2022. PMID: 35749312 Free PMC article.

1. Bastard P, Zhang Q, Zhang SY, Jouanguy E, Casanova JL. Type I interferons and SARS-CoV-2: from cells to organisms. Curr Opin Immunol 2022; 74:172–82. - PMC - PubMed
1. Chung H, Green PHR, Wang TC, Kong XF. Interferon-driven immune dysregulation in down syndrome: a review of the evidence. J Inflamm Res 2021; 14:5187–200. - PMC - PubMed
1. Aricò E, Bracci L, Castiello L, Urbani F, Casanova JL, Belardelli F. Exploiting natural antiviral immunity for the control of pandemics: lessons from Covid-19. Cytokine Growth Factor Rev 2022; 63:23–33. - PMC - PubMed
1. Espinosa JM. Down syndrome and COVID-19: a perfect storm? Cell Rep Med 2020; 1:100019. - PMC - PubMed
1. Verstegen RHJ, Kusters MAA. Inborn errors of adaptive immunity in Down syndrome. J Clin Immunol 2020; 40:791–806. - PubMed